| 宋瑞霖,李彦程.中国引入专利链接和专利期限补偿制度的研究[J].中国药事,2018,32(9):1161-1166 |
| 中国引入专利链接和专利期限补偿制度的研究 |
| Research on Introduction of Patent Linkage and Patent Term Compensation System in China |
| 投稿时间：2018-07-23 |
| DOI：10.16153/j.1002-7777.2018.09.001 |
| 中文关键词: 创新药 仿制药 专利链接 专利期补偿 |
| 英文关键词: innovative drug generic drug patent linkage patent term compensation |
| 基金项目: |
|
| 摘要点击次数: 2272 |
| 全文下载次数: 1174 |
| 中文摘要: |
| 目的：研究美国、欧洲和日本国家的药品专利保护制度和实践经验，为中国引入药品专利链接制度和专利期限补偿制度提供参考和建议。方法：通过文献资料研究和专家咨询等方式，分析在我国实施药品专利链接制度和专利期限补偿制度的必要性和可行性。结果：建立专利链接制度和专利期限补偿制度作为完善我国药品知识产权保护制度的重大举措，对于鼓励创新药研发、保护创新者权益、促进创新药与仿制药的平衡发展具有重大意义。制度设计应充分考量医药产业现状和发展方向，应该以促进产业结构调整和技术创新为目标。结论：应尽快建立适合我国国情的药品专利链接和专利期限补偿制度。 |
| 英文摘要: |
| Objective: To analyze the drug patent protection system and practical experience in the United States, Europe and Japan and to provide references and recommendations for the introduction of drug patent linkage and patent term compensation system in China.Methods: The necessity and feasibility of the implementation of drug patent linkage and patent term compensation system were analyzed by using the methods of literature research and expert consultation.Results: Establishing the patent linkage and patent term compensation system as an major measure to improve drug intellectual property protection system in China is of great significance for encouraging the development of innovative drugs, protecting the rights of innovators, and promoting the balanced development of innovative drugs and generic drugs. The current situation and development direction of the pharmaceutical industry should be fully considered during the system design with the purpose of promoting industrial restructuring and technological innovation.Conclusion: It is necessary to establish drug patent linkage and patent term compensation system suitable for pharmaceutical industrial situation in China as soon as possible. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |